Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme.

IF 3.5 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Adwoa Parker, Catherine Arundel, Laura Clark, Elizabeth Coleman, Laura Doherty, Catherine Elizabeth Hewitt, David Beard, Peter Bower, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Christopher J Sutton, Shaun Treweek, David J Torgerson
{"title":"Undertaking Studies Within A Trial to evaluate recruitment and retention strategies for randomised controlled trials: lessons learnt from the PROMETHEUS research programme.","authors":"Adwoa Parker, Catherine Arundel, Laura Clark, Elizabeth Coleman, Laura Doherty, Catherine Elizabeth Hewitt, David Beard, Peter Bower, Cindy Cooper, Lucy Culliford, Declan Devane, Richard Emsley, Sandra Eldridge, Sandra Galvin, Katie Gillies, Alan Montgomery, Christopher J Sutton, Shaun Treweek, David J Torgerson","doi":"10.3310/HTQW3107","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Randomised controlled trials ('trials') are susceptible to poor participant recruitment and retention. Studies Within A Trial are the strongest methods for testing the effectiveness of strategies to improve recruitment and retention. However, relatively few of these have been conducted.</p><p><strong>Objectives: </strong>PROMoting THE Use of Studies Within A Trial aimed to facilitate at least 25 Studies Within A Trial evaluating recruitment or retention strategies. We share our experience of delivering the PROMoting THE Use of Studies Within A Trial programme, and the lessons learnt for undertaking randomised Studies Within A Trial.</p><p><strong>Design: </strong>A network of 10 Clinical Trials Units and 1 primary care research centre committed to conducting randomised controlled Studies Within A Trial of recruitment and/or retention strategies was established. Promising recruitment and retention strategies were identified from various sources including Cochrane systematic reviews, the Study Within A Trial Repository, and existing prioritisation exercises, which were reviewed by patient and public members to create an initial priority list of seven recruitment and eight retention interventions. Host trial teams could apply for funding and receive support from the PROMoting THE Use of Studies Within A Trial team to undertake Studies Within A Trial. We also tested the feasibility of undertaking co-ordinated Studies Within A Trial, across multiple host trials simultaneously.</p><p><strong>Setting: </strong>Clinical trials unit-based trials recruiting or following up participants in any setting in the United Kingdom were eligible.</p><p><strong>Participants: </strong>Clinical trials unit-based teams undertaking trials in any clinical context in the United Kingdom.</p><p><strong>Interventions: </strong>Funding of up to £5000 and support from the PROMoting THE Use of Studies Within A Trial team to design, implement and report Studies Within A Trial.</p><p><strong>Main outcome measures: </strong>Number of host trials funded.</p><p><strong>Results: </strong>Forty-two Studies Within A Trial were funded (31 host trials), across 12 Clinical Trials Units. The mean cost of a Study Within A Trial was £3535. Twelve Studies Within A Trial tested the same strategy across multiple host trials using a co-ordinated Study Within A Trial design, and four used a factorial design. Two recruitment and five retention strategies were evaluated in more than one host trial. PROMoting THE Use of Studies Within A Trial will add 18% more Studies Within A Trial to the Cochrane systematic review of recruitment strategies, and 79% more Studies Within A Trial to the Cochrane review of retention strategies. For retention, we found that pre-notifying participants by card, letter or e-mail before sending questionnaires was effective, as was the use of pens, and sending personalised text messages to improve questionnaire response. We highlight key lessons learnt to guide others planning Studies Within A Trial, including involving patient and public involvement partners; prioritising and selecting strategies to evaluate and elements to consider when designing a Study Within A Trial; obtaining governance approvals; implementing Studies Within A Trial, including individual and co-ordinated Studies Within A Trials; and reporting Study Within A Trials.</p><p><strong>Limitations: </strong>The COVID-19 pandemic negatively impacted five Studies Within A Trial, being either delayed (<i>n</i> = 2) or prematurely terminated (<i>n</i> = 3).</p><p><strong>Conclusions: </strong>PROMoting THE Use of Studies Within A Trial significantly increased the evidence base for recruitment and retention strategies. When provided with both funding and practical support, host trial teams successfully implemented Studies Within A Trial.</p><p><strong>Future work: </strong>Future research should identify and target gaps in the evidence base, including widening Study Within A Trial uptake, undertaking more complex Studies Within A Trial and translating Study Within A Trial evidence into practice.</p><p><strong>Study registration: </strong>All Studies Within A Trial in the PROMoting THE Use of Studies Within A Trial programme had to be registered with the Northern Ireland Network for Trials Methodology Research Study Within A Trial Repository.</p><p><strong>Funding: </strong>This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/55/80) and is published in full in <i>Health Technology Assessment</i>; Vol. 28, No. 2. See the NIHR Funding and Awards website for further award information.</p>","PeriodicalId":12898,"journal":{"name":"Health technology assessment","volume":"28 2","pages":"1-114"},"PeriodicalIF":3.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11017159/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health technology assessment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3310/HTQW3107","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Randomised controlled trials ('trials') are susceptible to poor participant recruitment and retention. Studies Within A Trial are the strongest methods for testing the effectiveness of strategies to improve recruitment and retention. However, relatively few of these have been conducted.

Objectives: PROMoting THE Use of Studies Within A Trial aimed to facilitate at least 25 Studies Within A Trial evaluating recruitment or retention strategies. We share our experience of delivering the PROMoting THE Use of Studies Within A Trial programme, and the lessons learnt for undertaking randomised Studies Within A Trial.

Design: A network of 10 Clinical Trials Units and 1 primary care research centre committed to conducting randomised controlled Studies Within A Trial of recruitment and/or retention strategies was established. Promising recruitment and retention strategies were identified from various sources including Cochrane systematic reviews, the Study Within A Trial Repository, and existing prioritisation exercises, which were reviewed by patient and public members to create an initial priority list of seven recruitment and eight retention interventions. Host trial teams could apply for funding and receive support from the PROMoting THE Use of Studies Within A Trial team to undertake Studies Within A Trial. We also tested the feasibility of undertaking co-ordinated Studies Within A Trial, across multiple host trials simultaneously.

Setting: Clinical trials unit-based trials recruiting or following up participants in any setting in the United Kingdom were eligible.

Participants: Clinical trials unit-based teams undertaking trials in any clinical context in the United Kingdom.

Interventions: Funding of up to £5000 and support from the PROMoting THE Use of Studies Within A Trial team to design, implement and report Studies Within A Trial.

Main outcome measures: Number of host trials funded.

Results: Forty-two Studies Within A Trial were funded (31 host trials), across 12 Clinical Trials Units. The mean cost of a Study Within A Trial was £3535. Twelve Studies Within A Trial tested the same strategy across multiple host trials using a co-ordinated Study Within A Trial design, and four used a factorial design. Two recruitment and five retention strategies were evaluated in more than one host trial. PROMoting THE Use of Studies Within A Trial will add 18% more Studies Within A Trial to the Cochrane systematic review of recruitment strategies, and 79% more Studies Within A Trial to the Cochrane review of retention strategies. For retention, we found that pre-notifying participants by card, letter or e-mail before sending questionnaires was effective, as was the use of pens, and sending personalised text messages to improve questionnaire response. We highlight key lessons learnt to guide others planning Studies Within A Trial, including involving patient and public involvement partners; prioritising and selecting strategies to evaluate and elements to consider when designing a Study Within A Trial; obtaining governance approvals; implementing Studies Within A Trial, including individual and co-ordinated Studies Within A Trials; and reporting Study Within A Trials.

Limitations: The COVID-19 pandemic negatively impacted five Studies Within A Trial, being either delayed (n = 2) or prematurely terminated (n = 3).

Conclusions: PROMoting THE Use of Studies Within A Trial significantly increased the evidence base for recruitment and retention strategies. When provided with both funding and practical support, host trial teams successfully implemented Studies Within A Trial.

Future work: Future research should identify and target gaps in the evidence base, including widening Study Within A Trial uptake, undertaking more complex Studies Within A Trial and translating Study Within A Trial evidence into practice.

Study registration: All Studies Within A Trial in the PROMoting THE Use of Studies Within A Trial programme had to be registered with the Northern Ireland Network for Trials Methodology Research Study Within A Trial Repository.

Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 13/55/80) and is published in full in Health Technology Assessment; Vol. 28, No. 2. See the NIHR Funding and Awards website for further award information.

在试验中开展研究,评估随机对照试验的招募和保留策略:从 PROMETHEUS 研究计划中汲取的经验教训。
背景:随机对照试验("试验")很容易出现参与者招募和保留率低的问题。试验中研究 "是测试改善招募和留住参与者策略有效性的最有效方法。然而,这种研究开展得相对较少:促进使用 "试验范围内的研究 "旨在促进至少 25 项评估招募或保留策略的 "试验范围内的研究"。我们将分享我们实施 "促进在试验范围内使用研究 "计划的经验,以及在试验范围内开展随机研究的教训:设计:建立了一个由 10 个临床试验单位和 1 个初级保健研究中心组成的网络,该网络致力于开展随机对照的 "试验中的研究",对招募和/或保留策略进行评估。通过各种渠道,包括科克伦系统综述、"试验中的研究 "资料库以及现有的优先排序工作,确定了有前途的招募和保留策略,并由患者和公众成员对其进行审核,从而创建了一份包含七项招募干预措施和八项保留干预措施的初步优先列表。主办试验团队可向 "促进试验内研究的使用 "团队申请资金并获得支持,以开展 "试验内研究"。我们还测试了在多个主持试验中同时开展协调的 "试验中研究 "的可行性:环境:以临床试验单位为基础,在英国任何环境下招募或跟踪参与者的试验均符合条件:干预措施:干预措施:由 "促进试验内研究的使用 "团队提供高达5000英镑的资金和支持,以设计、实施和报告试验内研究:结果:结果:12 个临床试验单位共资助了 42 项 "试验中研究"(31 项主持试验)。一项 "同一试验范围内的研究 "的平均成本为 3535 英镑。有 12 项 "A 类研究 "采用协调 "A 类研究 "设计,在多项主持试验中测试了相同的策略,另有 4 项采用了因子设计。有两项招募策略和五项保留策略在不止一项主持试验中进行了评估。推广使用 "试验中的研究 "将使科克伦招募策略系统综述中的 "试验中的研究 "增加 18%,使科克伦保留策略综述中的 "试验中的研究 "增加 79%。在留住参与者方面,我们发现在发送问卷之前通过卡片、信件或电子邮件预先通知参与者是有效的,使用笔和发送个性化短信以提高问卷回复率也是有效的。我们强调了所学到的主要经验,以指导其他人规划 "试验范围内的研究",包括让患者和公众参与合作伙伴;在设计 "试验范围内的研究 "时优先考虑和选择评估策略及考虑要素;获得管理批准;实施 "试验范围内的研究",包括单独和协调 "试验范围内的研究";以及报告 "试验范围内的研究":COVID-19大流行对五项 "试验内研究 "产生了负面影响,这些 "试验内研究 "要么被推迟(2项),要么被提前终止(3项):推广使用 "试验范围内的研究 "大大增加了招募和保留策略的证据基础。在获得资金和实际支持的情况下,主办方试验团队成功实施了 "试验中研究":未来工作:未来的研究应找出证据基础的不足之处并有针对性地加以解决,包括扩大 "研究在试验中 "的吸收范围、开展更复杂的 "研究在试验中 "以及将 "研究在试验中 "的证据转化为实践:促进使用试验研究计划中的所有试验研究都必须在北爱尔兰试验方法研究网络的试验研究资料库中注册:该奖项由国家健康与护理研究所(NIHR)的健康技术评估计划资助(NIHR奖项编号:13/55/80),全文发表于《健康技术评估》(Health Technology Assessment)第28卷第2期。如需了解更多奖项信息,请访问 NIHR Funding and Awards 网站。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Health technology assessment
Health technology assessment 医学-卫生保健
CiteScore
6.90
自引率
0.00%
发文量
94
审稿时长
>12 weeks
期刊介绍: Health Technology Assessment (HTA) publishes research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信